amifostine anhydrous and mitoxantrone

amifostine anhydrous has been researched along with mitoxantrone in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Adler, S; Andric, T; Creech, S; Galvez, A; Gezer, S; Gregory, SA; Hsu, W; Jajeh, A; Larson, RA; Loew, J; Preisler, HD; Slivnick, D; Venugopal, P	1
Damiani, D; Ermacora, A; Masolini, P; Michelutti, A; Michieli, M; Russo, D; Stocchi, R	1

Reviews

1 review(s) available for amifostine anhydrous and mitoxantrone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for amifostine anhydrous and mitoxantrone

Article	Year
Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leukemia research, 2000, Volume: 24, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Pilot Projects; Prognosis; Radiation-Protective Agents; Treatment Outcome	2000

Article

Year

Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine).

Leukemia research, 2000, Volume: 24, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Pilot Projects; Prognosis; Radiation-Protective Agents; Treatment Outcome

2000

Other Studies

3 other study(ies) available for amifostine anhydrous and mitoxantrone

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Amifostine does not inhibit the toxic effects of anthracycline derivates or mitoxantrone on MDR tumor cell lines. Leukemia & lymphoma, 2001, Volume: 42, Issue:4 Topics: Amifostine; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP-Binding Cassette Transporters; Cell Division; Cytoprotection; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Humans; Mercaptoethylamines; Mitoxantrone; Radiation-Protective Agents; Tumor Cells, Cultured	2001